Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 3/20 | 0.31 |
| ▸ | HTR2C | P28335 | 3/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25693933 | 0.86 | BRD4 (0.39) | ESR1ESR2MAOAMAOBBRD4 | |
| SCHEMBL19681534 | 0.86 | BRD4 (0.39) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL17997247 | 0.86 | PTGDR2 (0.36) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL17997229 | 0.86 | PTGDR2 (0.36) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL17997225 | 0.84 | PTGDR2 (0.35) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL17997252 | 0.83 | MAOA (0.34) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL17997221 | 0.83 | MAOA (0.34) | MAOAMAOBBRD4ALOX5APFEN1 | |
| SCHEMBL5100185 | 0.82 | ESR1 (0.44) | ESR1ESR2 | |
| SCHEMBL17997283 | 0.81 | PTGDR2 (0.35) | ESR1ESR2BRD4HTR2AHTR2C | |
| SCHEMBL17997234 | 0.81 | HTR4 (0.33) | MAOAMAOBBRD4ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472570-B2 | Highly vertical dielectric liquid crystal compound, liquid crystal composition, and liquid crystal display device | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-12 | — | — | US | disclosed |
| US-20180119012-A1 | HIGHLY VERTICAL DIELECTRIC LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180119012-A1 | HIGHLY VERTICAL DIELECTRIC LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CCNB1, FLNB, CXCR1 | ESR1 1521/4885ESR2 1305/4885MAOA 3237/4885 |
| US-10472570-B2 | Highly vertical dielectric liquid crystal compound, liquid crystal composition, and liquid crystal display device | CCNB1, FLNB, CXCR1 | ESR1 1521/4885ESR2 1305/4885MAOA 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.